US panel review for Seroquel paediatric indications
This article was originally published in Scrip
Executive Summary
AstraZeneca said the US FDA's psychopharmacologic drugs advisory committee will convene on June 9th-10th to consider the first paediatric indications for the atypical antipsychotic Seroquel (quetiapine fumarate).